Asian Journal Of Social Pharmacy

Asian Journal of Social Pharmacy

20 September 2019, Volume 14 Issue 3 Previous Issue    Next Issue

Regulation of Drug Clinical Trials in China: Course and Development Trend

Zhang Xu, Tian Lijuan

2019, 14 (3): 87–91;

Abstract ( 454 ) PDF (2691KB) ( 596 )

Analysis of Laws and Regulations on Vaccine Quality Control in China

Zhi Yuanyuan, Wang Shuling, He Yalan

2019, 14 (3): 92–99;

Abstract ( 523 ) PDF (4148KB) ( 670 )

Group Purchasing Organizations (GPOs) in the U.S.: Development and Reform

Jin Jing, Xiong Jiamei, Yang Yue, Huang Zhe

2019, 14 (3): 100–109;

Abstract ( 790 ) PDF (2783KB) ( 6252 )

Risk Control Strategy in the Research and Development of Pediatric Drugs

Tang Ying, Chen Yuwen

2019, 14 (3): 110–118;

Abstract ( 516 ) PDF (4065KB) ( 386 )

Empirical Study of the Relations between Executive Compensation Gap and R&D Investment in Pharmaceutical Manufacturing Enterprises

Hu Liuyan, Liu Nanping, Xing Hua

2019, 14 (3): 119–125;

Abstract ( 627 ) PDF (2752KB) ( 1000 )

Analysis of the Current Situation of Active Pharmaceutical Ingredient (API) Export in China

Kong Deqiang, Dong Li

2019, 14 (3): 126–134;

Abstract ( 661 ) PDF (3643KB) ( 775 )

Licensed Pharmacists in Pharmaceutical Retail Enterprises in China: Problems and Countermeasures

Wang Shuling, De Xianhui, An Lianyu, Shi Ping

2019, 14 (3): 135–143;

Abstract ( 596 ) PDF (5897KB) ( 588 )

Pharmacy Service in Private Hospitals: Problems and Countermeasures

Lu Yiyang, Sun Lihua

2019, 14 (3): 144–150;

Abstract ( 663 ) PDF (3435KB) ( 539 )